Transient ischemic attack: Are there different types or classes? Risk of stroke and treatment options

Current Treatment Options in Cardiovascular Medicine

Volumn 8, Issue 3, 2006, Pages 193-200

  Ay, Hakan ^a   Koroshetz, Walter J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ANGIOPLASTY; ARTICLE; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; DISEASE DURATION; ELECTROCARDIOGRAPHY; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; LABORATORY DIAGNOSIS; LIFESTYLE; NEUROIMAGING; PATIENT COUNSELING; PHYSICAL ACTIVITY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TRANSIENT ISCHEMIC ATTACK;

EID: 33646766799     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-006-0012-z     Document Type: Article

References (44)

1. Toole JF, Lefkowitz DS, Chambless LE, et al.: Self-reported transient ischemic attack and stroke symptoms: methods and baseline prevalence. The ARIC Study, 1987-1989. Am J Epidemiol 1996, 144:849-856.
2. Ovbiagele B, Kidwell CS, Saver JL: Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack. Stroke 2003, 34:919-924.
3. Johnston SC, Fayad PB, Gorelick PB, et al.: Prevalence and knowledge of transient ischemic attack among US adults. Neurology 2003, 60:1429-1434.
4. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators [no authors listed]. J Clin Epidemiol 1988, 41:105-114.
5. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III [no authors listed]. Stroke 1990, 21:637-676.
6. Transient focal cerebral ischemia: epidemiological and clinical aspects. The Study Group on TIA Criteria and Detection. XI [no authors listed]. Stroke 1974, 5:277-284.
7. Marshall J: The natural history of transient ischaemic cerebrovascular attacks. QJM 1964, 33:309-324.
8. Levy DE: How transient are transient ischemic attacks? Neurology 1988, 38:674-677.
9. Albers GW, Caplan LR, Easton JD, et al.: Transient ischemic attack - proposal for a new definition. TIA Working Group. N Engl J Med 2002, 347:1713-1716.
10. Ay H, Oliveira-Filho J, Buonanno FS, et al.: "Footprints" of transient ischemic attacks: a diffusion-weighted MRI study. Cerebrovasc Dis 2002, 14:177-186.
11. Kidwell CS, Alger JR, Di Salle F, et al.: Diffusion MRI in patients with transient ischemic attacks. Stroke 1999, 30:1174-1180.
12. Engelter ST, Provenzale JM, Petrella JR, Alberts MJ: Diffusion MR imaging and transient ischemic attacks. Stroke 1999, 30:2762-2763.
13. Crisostomo RA, Garcia MM, Tong DC: Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation with clinical characteristics. Stroke 2003, 34:932-937.
14. Ferro JM, Falcao I, Rodrigues G, et al.: Diagnosis of transient ischemic attack by the nonneurologist. A validation study. Stroke 1996, 27:2225-2229.
15. Otten A, Nino YB, Limburg M, DeHaan R: Management of transient ischemic attacks by general practitioner. Cerebrovasc Dis 1995, 5:358-361.
16. Tomasello F, Mariani F, Fieschi C, et al.: Assessment of interobserver differences in the Italian multicenter study on reversible cerebral ischemia. Stroke 1982, 13:32-35.
17. Kraaijeveld CL, Van Gijn J, Schouten HJA, Staal A: Interobserver agreement for the diagnosis of transient ischemic attacks. Stroke 1984, 15:723-725.
18. Gass A, Ay H, Szabo K, Koroshetz WJ: Diffusion weighted MRI for the small stuff: the details of acute cerebral ischaemia. Lancet Neurol 2004, 3:39-45.
19. Marks MP, de Crespigny A, Lentz D, et al.: Acute and chronic stroke: navigated spin-echo diffusion-weighted MR imaging. Radiology 1996, 199:403-408.
20. Minematsu K, Li L, Sotak C, et al.: Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke 1992, 23:1304-1311.
21. Ay H, Buonanno FS, Rordorf G, et al.: Normal diffusion-weighted MRI during stroke-like deficits. Neurology 1999, 52:1784-1792.
22. Krol AL, Coutts SB, Simon JE, et al.: Perfusion MRI abnormalities in speech or motor transient ischemic attack patients. Stroke 2005, 36:2487-2489.
23. Ay H, Koroshetz J, Benner T, et al.: Transient ischemic attack with infarction: a unique syndrome? Ann Neurol 2005, 57:679-686.
24. Inatomi Y, Kimura K, Yonehara T, et al.: DWI abnormalities and clinical characteristics in TIA patients. Neurology 2004, 62:376-380.
25. Douglas VC, Johnston CM, Elkins J, et al.: Head computed tomography findings predict short term stroke risk after transient ischemic attack. Stroke 2003, 34:2894-2899.
26. Coutts SB, Simon JE, Eliasziw M, et al.: Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 2005, 57:848-854.
27. Purroy F, Montaner J, Rovira A, et al.: Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke 2004, 35:2313-2319.
28. Coutts SB, Simon JE, Sohn CH: Silent ischemia in minor stroke and TIA patients identified on MR imaging. Neurology 2005, 65:513-517.
29. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators [no authors listed]. JAMA 1998, 279:1265-1272.
30. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group [no authors listed]. Lancet 1997, 349:1569-1581.
31. Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.
32. Johnston SC, Sidney S, Bernstein AL, Gress DR: A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA. Neurology 2003, 60:280-285.
33. Fisher CM: Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci 1980, 7:9-17.
34. Rothwell PM, Giles MF, Flossmann E, et al.: A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 2005, 366:29-36.
35. Donnan GA, O'Malley HM, Quang L, et al.: The capsular warning syndrome: pathogenesis and clinical features. Neurology 1993, 43:957-962.
36. Farrar J, Donnan GA: Capsular warning syndrome preceding pontine infarction. Stroke 1993, 24:762.
37. Yadav JS, Wholey MH, Kuntz RE, et al.: Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004, 351:1493-1501.
38. Benavente O, Eliasziw M, Streifler JY, et al.: Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med 2001, 345:1084-1090.
39. Rothwell PM, Eliasziw M, Gutnikov SA, et al.: Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004, 363:915-924.
40. Chimowitz MI, Lynn MJ, Howlett-Smith H: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005, 352:1305-1316.
41. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. SSYLVIA Study Investigators [no authors listed]. Stroke 2004, 35:1388-1392.
42. Klijn CJ, Kappelle LJ, Tulleken CA, van Gijn J: Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. Stroke 1997, 28:2084-2093.
43. Grubb RL, Derdeyn CP, Fritsch SM, et al.: Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998, 280:1055-1060.
44. Adams RJ, Chimovitz MI, Alpert JS, et al.: Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation 2003, 108:1278-1290.